|
NDUFA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.804800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.757000E-01 |
| Normal-vs-Stage2 |
3.566100E-02 |
| Normal-vs-Stage3 |
6.665800E-01 |
| Normal-vs-Stage4 |
4.557800E-01 |
| Stage1-vs-Stage2 |
1.734320E-02 |
| Stage1-vs-Stage3 |
9.132000E-01 |
| Stage1-vs-Stage4 |
1.323820E-01 |
| Stage2-vs-Stage3 |
5.538500E-02 |
| Stage2-vs-Stage4 |
5.198100E-03 |
| Stage3-vs-Stage4 |
1.835640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.543800E-01 |
| Normal-vs-AfricanAmerican |
4.370400E-01 |
| Normal-vs-Asian |
7.558800E-01 |
| Caucasian-vs-AfricanAmerican |
3.271400E-01 |
| Caucasian-vs-Asian |
8.382400E-01 |
| AfricanAmerican-vs-Asian |
2.717600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.487190E-01 |
| Normal-vs-Female |
8.880000E-01 |
| Male-vs-Female |
6.130100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.958000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.040200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.041600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.200800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.400400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.514000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.781000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.704170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.290800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.839000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.883000E-01 |
| Classical-VS-Follicular |
3.0237000014921E-08 |
| Classical-VS-Other |
4.987600E-01 |
| Classical-VS-Normal |
3.901800E-01 |
| Tall-VS-Follicular |
1.78097999999904E-05 |
| Tall-VS-Other |
4.608600E-01 |
| Tall-VS-Normal |
4.328200E-01 |
| Follicular-VS-Other |
3.445800E-01 |
| Follicular-VS-Normal |
2.844400E-04 |
| Other-VS-Normal |
5.253800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.444650E-01 |
| Normal-vs-N1 |
3.069800E-01 |
| N0-vs-N1 |
7.918200E-01 |
|
|
